Zeria Pharmaceutical News and Activities
Presence
Zeria Pharmaceutical develops, manufactures, and sells prescription medicines, over the counter medicines, and health products. It serves hospitals, clinics, pharmacies, and consumers in Japan and overseas markets.
Zeria Pharmaceutical products and services overview:
- Prescription drugs
- OTC medicines
- Digestive health
- Dermatology products
- Health supplements
- Consumer healthcare
Revenue: ~$500 million
Employees: 2,100
Headquarters: Tokyo, Japan
Zeria Pharmaceutical is one of the...
Zeria Pharmaceutical is a company listed under the stock ticker 4559 (JP).
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Zeria Pharmaceutical
- Sachiaki Ibe, Chairman of the Board, Chief Executive Officer and R...
- Yuuki Okazawa, Supervisory Board Member
- Kikuo Nomoto, Independent Director
Create your alert
to follow the executive moves at Zeria Pharmaceutical.
Biotechnology
Zeria Pharmaceutical has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Zeria Pharmaceutical
Social media about Zeria Pharmaceutical
- Zeria Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Zeria Pharmaceutical on LinkedIn, X (Twitter) & YouTube
